Key result
Renal transplant patients had a significantly higher mean Torque Teno Virus viral load compared to hemodialysis patients (6.3 log vs 5.0 log copies/ml, P=0.001).
Population
80 patients, mean age 61, 70% male, from a single teaching hospital in New South Wales, Australia.
Design
Cross-sectional
Authors
Loading...
Provides first Australian TTV prevalence data in renal patients; leaves open its role as immunosuppression biomarker pending prospective validation.
Cross-Sectional (n=80)
No
Absolute Event Rate: 6.3% vs 5%
p-value: p=0.001
Torque teno virus is highly prevalent in Australian renal patients, with higher viral loads in transplant recipients, suggesting its potential as a marker for immunosuppression.
Davis et al. (2020) conducted a cross-sectional in Hemodialysis and renal transplant (n=80). Renal transplantation (immunosuppression) vs. Hemodialysis (no immunosuppression) was evaluated on Mean TTV viral load (log copies/ml) (p=0.001). Renal transplant patients had a significantly higher mean Torque Teno Virus viral load compared to hemodialysis patients (6.3 log vs 5.0 log copies/ml, P=0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: